• | Consolidated net sales increased 10.1% to $95.0 million, reflecting growth in both the Distillery Products and Ingredient Solutions segments. |
• | Consolidated gross profit increased 5.2% to $19.6 million from $18.6 million, driven by gross profit growth in the Ingredient Solutions segment, partially offset by a decline in the Distillery Products segment. |
• | Consolidated operating income increased 14.7% to $12.0 million, from $10.5 million in the prior-year quarter, primarily driven by an increase in gross profit in the Ingredient Solutions segment and a decrease in SG&A expenses. |
• | Earnings per share decreased to $0.52 per share from $0.82 per share in the prior-year quarter, primarily due to the gain on sale of equity method investment recorded in the third quarter of 2017 from the successful sale of Illinois Corn Processing, LLC, partially offset by the decrease in the effective tax rate and an increase in operating income. |
Food Grade Alcohol (in thousands) | Net Sales Quarter Ended September 30, | Quarter vs. Quarter Net Sales Change Increase/(Decrease) | |||||||||||||||||
2018 | 2017 | $ Change | % Change | ||||||||||||||||
Premium Beverage Alcohol | $ | 46,864 | $ | 43,941 | $ | 2,923 | 6.7 | % | |||||||||||
Industrial Alcohol | 20,661 | 19,310 | 1,351 | 7.0 | |||||||||||||||
Food Grade Alcohol | $ | 67,525 | $ | 63,251 | $ | 4,274 | 6.8 | % |
• | Operating income is expected to grow between 10% and 15% for fiscal year 2018. |
• | The Company’s conservative estimate of growth in operating income in 2019 is 15% to 20% as sales of aged whiskey inventory become a more significant factor. |
• | 2018 net sales growth is projected in the high single-digit percentage range versus 2017, subject to some volatility as the Company continues to shift sales from industrial to premium beverage alcohol. |
• | 2018 gross margins are expected to continue to be consistent with 2017. |
• | 2018 effective tax rate is forecast to be 24%, and shares outstanding are expected to be approximately 16.9 million at year end. |
Operating income, quarter versus quarter | Operating Income | Change | ||||||
Operating income for quarter ended September 30, 2017 | $ | 10,471 | ||||||
Increase in gross profit - ingredient solutions segment | 1,206 | 11.5 | pp(a) | |||||
Decrease in gross profit - distillery products segment | (232 | ) | (2.2 | ) | pp | |||
Decrease in SG&A expenses | 570 | 5.4 | pp | |||||
Operating income for quarter ended September 30, 2018 | $ | 12,015 | 14.7 | % |
Operating income, year to date versus year to date | Operating Income | Change | ||||||
Operating income for year to date ended September 30, 2017 | $ | 32,377 | ||||||
Increase in gross profit - ingredient solutions segment | 1,750 | 5.4 | pp(a) | |||||
Decrease in gross profit - distillery products segment | (250 | ) | (0.8 | ) | pp | |||
Increase in SG&A expenses | (341 | ) | (1.0 | ) | pp | |||
Operating income for year to date ended September 30, 2018 | $ | 33,536 | 3.6 | % |
Change in basic and diluted EPS, quarter versus quarter | Basic and Diluted EPS | Change | ||||||
Basic and diluted EPS for quarter ended September 30, 2017 | $ | 0.82 | ||||||
Increase in operations(a) | 0.06 | 7.3 | pp(b) | |||||
Decrease in gain on sale of equity method investment(a) | (0.44 | ) | (53.7 | ) | pp | |||
Tax: Change in effective tax rate | 0.07 | 8.6 | pp | |||||
Decrease in income attributable to participating securities | 0.01 | 1.2 | ||||||
Basic and diluted EPS for quarter ended September 30, 2018 | $ | 0.52 | (36.6 | )% |
(a) | Items are net of tax based on the effective tax rate for the base year (2017). |
(b) | Percentage points ("pp"). |
Change in basic and diluted EPS, year to date versus year to date | Basic and Diluted EPS | Change | ||||||
Basic and diluted EPS for year to date ended September 30, 2017 | $ | 1.70 | ||||||
Increase in operations(a) | 0.05 | 2.9 | pp(b) | |||||
Decrease in equity method investment loss(a) | 0.01 | 0.6 | pp | |||||
Decrease in gain on sale of equity method investment(a) | (0.44 | ) | (25.9 | ) | pp | |||
Tax: Change in effective tax rate | 0.14 | 8.2 | pp | |||||
Decrease in income attributable to participating securities | 0.02 | 1.3 | pp | |||||
Basic and diluted EPS for year to date ended September 30, 2018 | $ | 1.48 | (12.9 | )% |
(a) | Items are net of tax based on the effective tax rate for the base year (2017), excluding the effect of the tax benefit on vested share-based compensation on the 2017 rate. |
(b) | Percentage points ("pp"). |
Quarter Ended | Year to date Ended | ||||||||||||||||
September 30, 2018 | September 30, 2017 | September 30, 2018 | September 30, 2017 | ||||||||||||||
Net sales | $ | 95,031 | $ | 86,333 | $ | 271,239 | $ | 259,255 | |||||||||
Cost of sales | 75,432 | 67,708 | 213,248 | 202,764 | |||||||||||||
Gross profit | 19,599 | 18,625 | 57,991 | 56,491 | |||||||||||||
Selling, general and administrative expenses | 7,584 | 8,154 | 24,455 | 24,114 | |||||||||||||
Operating income | 12,015 | 10,471 | 33,536 | 32,377 | |||||||||||||
Gain on sale of equity method investment | — | 11,381 | — | 11,381 | |||||||||||||
Equity method investment loss | — | — | — | (348 | ) | ||||||||||||
Interest expense, net | (334 | ) | (224 | ) | (830 | ) | (934 | ) | |||||||||
Income before income taxes | 11,681 | 21,628 | 32,706 | 42,476 | |||||||||||||
Income tax expense | 2,673 | 7,491 | 7,244 | 13,292 | |||||||||||||
Net income | $ | 9,008 | $ | 14,137 | $ | 25,462 | $ | 29,184 | |||||||||
Income attributable to participating securities | 174 | 414 | 491 | 806 | |||||||||||||
Net income attributable to common shareholders and used in EPS calculation | $ | 8,834 | $ | 13,723 | $ | 24,971 | $ | 28,378 | |||||||||
Share information: | |||||||||||||||||
Basic and Diluted weighted average common shares | 16,872,091 | 16,751,346 | 16,861,700 | 16,735,378 | |||||||||||||
Basic and diluted earnings per common share | $ | 0.52 | $ | 0.82 | $ | 1.48 | $ | 1.70 | |||||||||
Dividends and dividend equivalents per common share | $ | 0.08 | $ | 0.89 | $ | 0.24 | $ | 0.97 |
(Dollars in thousands) | September 30, 2018 | December 31, 2017 | (Dollars in thousands) | September 30, 2018 | December 31, 2017 | |||||||||||
ASSETS | LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||
Current Assets: | Current Liabilities: | |||||||||||||||
Cash and cash equivalents | $ | — | $ | 3,084 | Current maturities of long-term debt | $ | 382 | $ | 372 | |||||||
Receivables, net | 49,991 | 34,347 | Accounts payable | 22,905 | 30,037 | |||||||||||
Inventory | 107,346 | 93,149 | Accrued expenses | 8,545 | 11,171 | |||||||||||
Prepaid expenses | 1,885 | 2,182 | ||||||||||||||
Refundable income taxes | 2,011 | 1,980 | Total Current Liabilities | 31,832 | 41,580 | |||||||||||
Total Current Assets | 161,233 | 134,742 | Other Liabilities: | |||||||||||||
Long-term debt, less current maturities | 21,133 | 21,407 | ||||||||||||||
Revolving credit facility | 23,605 | 2,775 | ||||||||||||||
Deferred credits | 1,687 | 2,151 | ||||||||||||||
Property and equipment | 282,271 | 267,288 | Accrued retirement, health, and life insurance benefits | 2,913 | 3,133 | |||||||||||
Less accumulated depreciation and amortization | (172,344 | ) | (164,237 | ) | Other noncurrent liabilities | 1,112 | 540 | |||||||||
Net Property, Plant, and Equipment | 109,927 | 103,051 | Deferred income taxes | 936 | 12 | |||||||||||
Total Liabilities | 83,218 | 71,598 | ||||||||||||||
Other assets | 2,420 | 2,535 | Stockholders’ equity | 190,362 | 168,730 | |||||||||||
TOTAL ASSETS | $ | 273,580 | $ | 240,328 | TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 273,580 | $ | 240,328 |
Year to Date Ended | ||||||||
September 30, 2018 | September 30, 2017 | |||||||
Cash Flows from Operating Activities | ||||||||
Net income | $ | 25,462 | $ | 29,184 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 8,529 | 8,441 | ||||||
Distributions received from equity method investee | — | 7,131 | ||||||
Deferred income taxes | 924 | 356 | ||||||
Share-based compensation | 2,464 | 2,130 | ||||||
Gain on sale of equity method investment | — | (11,381 | ) | |||||
Equity method investment loss | — | 348 | ||||||
Changes in operating assets and liabilities: | ||||||||
Receivables, net | (15,644 | ) | (11,366 | ) | ||||
Inventory | (14,197 | ) | (10,794 | ) | ||||
Prepaid expenses | 297 | (824 | ) | |||||
Accounts payable | (3,453 | ) | 4,193 | |||||
Accounts payable to affiliate, net | — | (3,349 | ) | |||||
Accrued expenses | (2,623 | ) | 790 | |||||
Income taxes payable/refundable | (31 | ) | 2,472 | |||||
Deferred credit | (464 | ) | (617 | ) | ||||
Accrued retirement health and life insurance benefits | 395 | (267 | ) | |||||
Net cash provided by operating activities | 1,659 | 16,447 | ||||||
Cash Flows from Investing Activities | ||||||||
Additions to plant, property and equipment | (18,870 | ) | (13,630 | ) | ||||
Return of equity method investment | — | 22,832 | ||||||
Proceeds from property insurance recoveries | — | 14 | ||||||
Net cash provided by (used in) investing activities | (18,870 | ) | 9,216 | |||||
Cash Flows from Financing Activities | ||||||||
Purchase of treasury stock for tax withholding on equity-based compensation | (2,215 | ) | (1,377 | ) | ||||
Payment of dividends and dividend equivalents | (4,125 | ) | (16,692 | ) | ||||
Proceeds on long-term debt | — | 20,000 | ||||||
Principal payments on long-term debt | (279 | ) | (268 | ) | ||||
Proceeds from credit agreement - revolver | 22,766 | 20,580 | ||||||
Payments on credit agreement - revolver | (2,020 | ) | (41,985 | ) | ||||
Loan fees incurred with borrowings | — | (377 | ) | |||||
Net cash provided by (used in) financing activities | 14,127 | (20,119 | ) | |||||
Increase (decrease) in cash and cash equivalents | (3,084 | ) | 5,544 | |||||
Cash and cash equivalents, beginning of period | 3,084 | 1,569 | ||||||
Cash and cash equivalents, end of period | $ | — | $ | 7,113 |